AA
ALDR

ALPS Advisors’s Alder Biopharmaceuticals ALDR Stock Holding History

ALPS Advisors’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-43,366
Closed -$902K – 798
2017
Q1 		$902K Sell
43,366
-4,968
-10% -$110K 0.01% 227
2016
Q4 		$1M Sell
48,334
-15,644
-24% -$407K 0.01% 218
2016
Q3 		$2.1M Buy
+63,978
New +$1.95M 0.02% 180
2016
Q1 		– Sell
-57,452
Closed -$1.9M – 797
2015
Q4 		$1.9M Sell
57,452
-10,654
-16% -$360K 0.02% 184
2015
Q3 		$22.3K Buy
68,106
+30,477
+81% +$1.3M 0.02% 163
2015
Q2 		$1.99M Buy
37,629
+19,367
+106% +$704K 0.02% 169
2015
Q1 		$527K Buy
+18,262
New +$501K ﹤0.01% 414

Other funds holding ALDR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return